Redhill Biopharma Ltd.
Sector: Manufacturing
Industry: Pharmaceutical Products
2.00
0.02
(1.01%)
Volume:
8,060
52 week range:
1.72 - 20.28
Market Cap:
2.580B
Company Description:
RedHill Biopharma Ltd. primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections.